Zika Virus Market

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don?t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don?t have Zika symptoms lives in or traveled to an area with risk of Zika.

Zika Virus Market contains market size and forecasts of Zika Virus in global, including the following market information:

Global Zika Virus Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Zika Virus Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Zika Virus companies in 2021 (%)

The global Zika Virus market was valued at 119.4 million in 2021 and is projected to reach US$ 146.5 million by 2028, at a CAGR of 3.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Molecular Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Zika Virus include Bharat Biotech, Inovio Pharmaceuticals and GeneOne Life Sciences, Intrexon, Cerus, Sanofi, NewLink Genetics, Immunovaccine and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Zika Virus manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Zika Virus Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Zika Virus Market Segment Percentages, by Type, 2021 (%)

Molecular Test

Serologic Test

Global Zika Virus Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Zika Virus Market Segment Percentages, by Application, 2021 (%)

Diagnostic Centers

Hospitals

Pathology Labs

Global Zika Virus Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Zika Virus Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Zika Virus revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Zika Virus revenues share in global market, 2021 (%)

Key companies Zika Virus sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Zika Virus sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bharat Biotech

Inovio Pharmaceuticals and GeneOne Life Sciences

Intrexon

Cerus

Sanofi

NewLink Genetics

Immunovaccine

GlaxoSmithKline